Status:
COMPLETED
Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Respiratory Distress Syndrome, Adult
Eligibility:
All Genders
18+ years
Brief Summary
Acute lung injury (ALI) is a severe lung condition that causes respiratory failure. The ARDS Network (ARDSNet) is a National Heart, Lung, and Blood Institute-sponsored network that is focused on impro...
Detailed Description
ALI, a life-threatening condition that involves inflammation of the lungs and fluid accumulation in the air sacs, typically leads to low blood oxygen levels and respiratory failure. Common causes of A...
Eligibility Criteria
Inclusion
- Participated in the ALTA, EDEN, OMEGA, or SAILS study
- Survived until hospital discharge
Exclusion
- Does not understand or speak English
- Has no fixed address
- Pre-existing cognitive impairment that prevents completion of the study assessments
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
922 Patients enrolled
Trial Details
Trial ID
NCT00719446
Start Date
October 1 2007
End Date
October 1 2014
Last Update
September 1 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201
2
Johns Hopkins University
Baltimore, Maryland, United States, 21205
3
Wake Forest University
Winston-Salem, North Carolina, United States, 27157
4
Vanderbilt University
Nashville, Tennessee, United States, 37232